We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Key Protein Differences Found in Sporadic and Inherited Alzheimer's

Key Protein Differences Found in Sporadic and Inherited Alzheimer's

Key Protein Differences Found in Sporadic and Inherited Alzheimer's

Key Protein Differences Found in Sporadic and Inherited Alzheimer's

Credit: Robina Weermeijer/ Unsplash
Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Key Protein Differences Found in Sporadic and Inherited Alzheimer's"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Indiana University School of Medicine researchers are making new discoveries about the pathological changes in people who have inherited Alzheimer’s disease versus developing the disease sporadically. These findings could lead to new ways of preventing and treating the disease.

In a new paper published in Science, researchers from the MRC Laboratory of Molecular Biology in Cambridge, England, United Kingdom and IU School of Medicine detail new findings about senile plaques, which are made up of a peptide called Amyloid-β 42 (Aβ 42). The study shows for the first time that the structure of the Aβ 42 filaments is different in sporadic and inherited Alzheimer’s disease. Type I filaments were found mostly in the brains of individuals with sporadic Alzheimer’s disease and Type II filaments were found in individuals with familial Alzheimer’s disease or other neurodegenerative conditions.

“Although senile plaques have been known to be one of the main pathological changes in Alzheimer’s disease for over a century, their nature and composition has been gradually unraveled during the past four decades,” said Bernardino Ghetti, MD, a distinguished professor and professor of pathology and laboratory medicine at IU School of Medicine. Ghetti is a corresponding author of the paper and a lead researcher at the Indiana Alzheimer’s Disease Research Center.

Researchers looked at cryogenic electron microscopy maps and 3D structures of Aβ 42 from the brains of five patients with Alzheimer’s disease and from five patients with different neurodegenerative conditions. Patients had either sporadic Alzheimer’s disease or dominantly inherited Alzheimer’s disease with a mutation in the APP or PSEN1 genes.

“This new knowledge of the filament structures provides deeper insights into the disease process in Alzheimer’s and may lead to the development of compounds that can prevent the disease by inhibiting filament formation as well as new methods for brain imaging,” Ghetti said. “This paper opens a new chapter for imaging and therapeutics.”

Reference: Yang Y, Arseni D, Zhang W, et al. Cryo-EM structures of amyloid-β 42 filaments from human brains. Science. 2022. doi: 10.1126/science.abm7285

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.